Table 2.
Age stratification of patients with biopsy proven renal disease according to their clinical indications.
| Clinical indications | Age (years old) | |||||
|---|---|---|---|---|---|---|
| ≤ 14, N (%) | 15–19, N (%) | 20–39, N (%) | 40–59, N (%) | ≥ 60, N (%) | Total, N (%) | |
| NS | 1,806 (53.53) | 1,574 (72.57) | 5,558 (45.02) | 6,137 (50.24) | 2,863 (63.24) | 17,938 (51.80) |
| Nephritic syndrome | 1,420 (42.09) | 486 (22.41) | 5,166 (41.85) | 4,513 (36.95) | 924 (20.41) | 12,509 (36.12) |
| ANS | 51 (1.51) | 12 (0.55) | 19 (0.15) | 6 (0.05) | 2 (0.04) | 90 (0.26) |
| RPGN | 9 (0.27) | 5 (0.23) | 81 (0.66) | 188 (1.54) | 217 (4.79) | 500 (1.44) |
| AUA | 9 (0.27) | 8 (0.37) | 140 (1.13) | 61 (0.50) | 4 (0.09) | 222 (0.64) |
| AKI | 19 (0.56) | 30 (1.38) | 220 (1.78) | 244 (2.00) | 157 (3.47) | 670 (1.93) |
| CKD | 60 (1.78) | 54 (2.49) | 1,161 (9.40) | 1,066 (8.73) | 360 (7.95) | 2,701 (7.80) |
| Total,N (%) | 3,374 (100) | 2,169 (100) | 12,345 (100) | 12,215 (100) | 4,527 (100) | 34,630 (100) |